Product
Aromatase inhibitor and GnRH analog
1 clinical trial
3 indications
Indication
AdenomyosisIndication
Recurrent Implantation FailureIndication
DysmenorrheaClinical trial
A Controlled Trial on Adenomyosis Treatment Comparing Aromatase Inhibitor Plus GnRH Analogue Versus GnRH Analog AloneStatus: Active (not recruiting), Estimated PCD: 2024-09-30